"At GenesisCare, we offer multidisciplinary personalised cancer treatments based on the needs of our patients as individuals. Our focus is on building relationships with humans that get us talked about long after treatment ends. We're an organisation with a local, national and global presence, providing care where it's needed. Our radiation and medical oncologists are among the world's leading specialists in the treatment of cancer. We invest in innovative treatments, advanced technologies and clinical trials with the goal to continually improve patient outcomes. Our services include radiation oncology, medical oncology and theranostics."

During the past decade, GenesisCare conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GenesisCare" are "Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "GenesisCare" in a lesser frequency.

Most popular intervention types in "GenesisCare" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Eplontersen" (1 trials), "Placebo" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GenesisCare". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GenesisCare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".